Systemic adjuvant therapy for high-risk cutaneous melanoma by Iyad Kobeissi, Ahmad A. Tarhini

Get full text

The use of immunotherapy in the treatment of melanoma by Tala Achkar, Ahmad A. Tarhini

Get full text

Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field by Islam Eljilany, Ella Castellano, Ahmad A. Tarhini

Get full text

Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma Patients. by Kathan Mehta, Leonard Appleman, Hong Wang, Ahmad A Tarhini, Rahul A Parikh

Get full text

Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases by Mariam Lotfy Khaled, Ahmad A. Tarhini, Peter A. Forsyth, Inna Smalley, Yolanda Piña

Get full text

The impact of CTLA-4 blockade and interferon-α on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients by Arjun Khunger, Julie A. Rytlewski, Paul Fields, Erik C. Yusko, Ahmad A. Tarhini

Get full text

A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab by Iyad Kobeissi, Islam Eljilany, Tala Achkar, William A. LaFramboise, Lucas Santana-Santos, Ahmad A. Tarhini

Get full text

Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma by Janet Retseck, Alexis Nasr, Yan Lin, Huang Lin, Prateek Mendiratta, Lisa H. Butterfield, Ahmad A. Tarhini

Get full text

Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit by Ahmad A. Tarhini, Yan Lin, Hui-Min Lin, Priyanka Vallabhaneni, Cindy Sander, William LaFramboise, Lana Hamieh

Get full text

Neoadjuvant immunotherapy of locoregionally advanced solid tumors by John Wright, Patrick M Forde, Robert L Ferris, Ahmad A Tarhini, Kathleen N Moore, Jennifer R Eads, Valerie Tatard-Leitman

Get full text

Case Report: Durable complete pathologic response and organ preservation following ipilimumab and nivolumab for locally advanced primary vaginal mucosal melanoma by Ahmad A. Tarhini, Wissam B. Hanayneh, John J. Powers, Carlos M. Moran Segura, Jose R. Conejo-Garcia, Cesar A. Lam, Ardeshir Hakam, Mitchel S. Hoffman

Get full text

Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma by Julian A. Marin-Acevedo, Bethany M. Withycombe, Youngchul Kim, Andrew S. Brohl, Zeynep Eroglu, Joseph Markowitz, Ahmad A. Tarhini, Kenneth Y. Tsai, Nikhil I. Khushalani

Get full text

CTLA-4 blockade and interferon-α induce proinflammatory transcriptional changes in the tumor immune landscape that correlate with pathologic response in melanoma. by Arjun Khunger, Erin Piazza, Sarah Warren, Thomas H Smith, Xing Ren, Andrew White, Nathan Elliott, Alessandra Cesano, Joseph M Beechem, John M Kirkwood, Ahmad A Tarhini

Get full text

782-I Phase I dose escalation of SAR445710, a PDL1-IL15 targeted cytokine in metastatic and/or advanced solid tumors by Jason Luke, Ahmad A Tarhini, Anthony J Olszanski, Chen Zhu, Giovanni Abbadessa, Christos Fountzilas, Lee Rosen, Adyb Baakili, Timothy Wagenaar, Helene Guillemin-Paveau, Meijing Wu, Raymond Perez

Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 P... by Islam Eljilany, Arish Noor, Mahati Paravathaneni, Ibrahim Yassine, Sandra J. Lee, Megan Othus, James Moon, John M. Kirkwood, Vernon K. Sondak, Antoni Ribas, Kenneth F. Grossmann, Ahmad A. Tarhini

Get full text

Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab. by Ahmad A Tarhini, Howard Edington, Lisa H Butterfield, Yan Lin, Yongli Shuai, Hussein Tawbi, Cindy Sander, Yan Yin, Matthew Holtzman, Jonas Johnson, Uma N M Rao, John M Kirkwood

Get full text

Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma by Lilit Karapetyan, William Gooding, Aofei Li, Xi Yang, Andrew Knight, Hassan M. Abushukair, Danielle Vargas De Stefano, Cindy Sander, Arivarasan Karunamurthy, Monica Panelli, Walter J. Storkus, Ahmad A. Tarhini, John M. Kirkwood

Get full text

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma by Lisa H. Butterfield, Lazar Vujanovic, Patricia M. Santos, Deena M. Maurer, Andrea Gambotto, Joel Lohr, Chunlei Li, Jacob Waldman, Uma Chandran, Yan Lin, Huang Lin, Hussein A. Tawbi, Ahmad A. Tarhini, John M. Kirkwood

Get full text

726 Establishing proof of mechanism in patients: preliminary biomarker data of SRK-181 (a latent TGFβ1 inhibitor) from DRAGON Study by Minal Barve, Ahmad A Tarhini, Deepak Kilari, Randy Sweis, Timothy Yap, John Clark, Justin Gainor, Lu Gan, Ulka N Vaishampayan, Amna Sher, Yawen Ju, Susan Henry, Stephen DeWall, Asia McCune, Mo Qatanani

666 Safety, efficacy, and biomarker results of SRK-181, a latent TGFβ1 inhibitor, in anti-PD-1 resistant metastatic ccRCC patients by Minal Barve, Ahmad A Tarhini, Deepak Kilari, Rana Mckay, Randy Sweis, Timothy Yap, Justin Gainor, Raghad Karim, Lu Gan, Lan Liu, David Park, Ulka N Vaishampayan, Amna Sher, Sunil Babu, Yawen Ju, Susan Henry